E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for Ariad Pharmaceuticals Inc. > News item
Published on 9/7/2006 in the Prospect News Biotech Daily.

JMP drops Ariad at market outperform

JMP Securities analyst Charles C. Duncan dropped coverage of Ariad Pharmaceuticals, Inc. due to a change in coverage focus. JMP had rated Ariad at market outperform. Shares of the Cambridge, Mass.-based pharmaceutical company were down 38 cents, or 8.23%, at $4.24. (Nasdaq: ARIA)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.